135 related articles for article (PubMed ID: 19297023)
21. NKG2D-dependent activation of dendritic epidermal T cells in contact hypersensitivity.
Nielsen MM; Dyring-Andersen B; Schmidt JD; Witherden D; Lovato P; Woetmann A; Ødum N; Poulsen SS; Havran WL; Geisler C; Bonefeld CM
J Invest Dermatol; 2015 May; 135(5):1311-1319. PubMed ID: 25634359
[TBL] [Abstract][Full Text] [Related]
22. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.
O'Callaghan CA; Cerwenka A; Willcox BE; Lanier LL; Bjorkman PJ
Immunity; 2001 Aug; 15(2):201-11. PubMed ID: 11520456
[TBL] [Abstract][Full Text] [Related]
23. Memory CD8 T Cells Generated by Cytomegalovirus Vaccine Vector Expressing NKG2D Ligand Have Effector-Like Phenotype and Distinct Functional Features.
Šustić M; Cokarić Brdovčak M; Lisnić B; Materljan J; Juranić Lisnić V; Rožmanić C; Indenbirken D; Hiršl L; Busch DH; Brizić I; Krmpotić A; Jonjić S
Front Immunol; 2021; 12():681380. PubMed ID: 34168650
[TBL] [Abstract][Full Text] [Related]
24. Correlation Between NKG2DL Expression and Antitumor Effect of Protein-bound Polysaccharide-K in Tumor-bearing Mouse Models.
Konagai A; Yoshimura K; Hazama S; Yamamoto N; Aoki K; Ueno T; Fujioka M; Iijima H; Kato M; Uchida M; Wada T; Inoue M; Asao T; Fuse M; Wada S; Kuramasu A; Kamei R; Takeda S; Yamamoto S; Yoshino S; Oka M; Nagano H
Anticancer Res; 2017 Aug; 37(8):4093-4101. PubMed ID: 28739693
[TBL] [Abstract][Full Text] [Related]
25. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.
Cerwenka A; Bakker AB; McClanahan T; Wagner J; Wu J; Phillips JH; Lanier LL
Immunity; 2000 Jun; 12(6):721-7. PubMed ID: 10894171
[TBL] [Abstract][Full Text] [Related]
27. IFN-dependent down-regulation of the NKG2D ligand H60 on tumors.
Bui JD; Carayannopoulos LN; Lanier LL; Yokoyama WM; Schreiber RD
J Immunol; 2006 Jan; 176(2):905-13. PubMed ID: 16393975
[TBL] [Abstract][Full Text] [Related]
28. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation.
Tokuyama M; Lorin C; Delebecque F; Jung H; Raulet DH; Coscoy L
PLoS Pathog; 2011 Sep; 7(9):e1002265. PubMed ID: 21966273
[TBL] [Abstract][Full Text] [Related]
29. The effect of renal ischemia-reperfusion injury on expression of RAE-1 and H60 in mice kidney.
Feng L; Cheng F; Ye Z; Li S; He Y; Yao X; Tang Q; Li Y
Transplant Proc; 2006 Sep; 38(7):2195-8. PubMed ID: 16980040
[TBL] [Abstract][Full Text] [Related]
30. The p36 isoform of murine cytomegalovirus m152 protein suffices for mediating innate and adaptive immune evasion.
Fink A; Renzaho A; Reddehase MJ; Lemmermann NA
Viruses; 2013 Dec; 5(12):3171-91. PubMed ID: 24351798
[TBL] [Abstract][Full Text] [Related]
31. MHC class I-like genes in cattle, MHCLA, with similarity to genes encoding NK cell stimulatory ligands.
Larson JH; Rebeiz MJ; Stiening CM; Windish RL; Beever JE; Lewin HA
Immunogenetics; 2003 Apr; 55(1):16-22. PubMed ID: 12679856
[TBL] [Abstract][Full Text] [Related]
32. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
J Immunol; 2005 Oct; 175(8):5541-50. PubMed ID: 16210663
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.
Chalupny NJ; Rein-Weston A; Dosch S; Cosman D
Biochem Biophys Res Commun; 2006 Jul; 346(1):175-81. PubMed ID: 16750166
[TBL] [Abstract][Full Text] [Related]
35. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion.
Kavanagh DG; Gold MC; Wagner M; Koszinowski UH; Hill AB
J Exp Med; 2001 Oct; 194(7):967-78. PubMed ID: 11581318
[TBL] [Abstract][Full Text] [Related]
36. NKG2D Signaling: The Immune Subversive Side of HDAC3.
Folgueras AR; Gonzalez S; López-Soto A
Trends Immunol; 2017 Mar; 38(3):151-153. PubMed ID: 28089218
[TBL] [Abstract][Full Text] [Related]
37. The NKG2D ligands RAE-1δ and RAE-1ε differ with respect to their receptor affinity, expression profiles and transcriptional regulation.
Cédile O; Popa N; Pollet-Villard F; Garmy N; Ibrahim EC; Boucraut J
PLoS One; 2010 Oct; 5(10):e13466. PubMed ID: 20976056
[TBL] [Abstract][Full Text] [Related]
38. Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon.
Nausch N; Florin L; Hartenstein B; Angel P; Schorpp-Kistner M; Cerwenka A
J Immunol; 2006 Jan; 176(1):7-11. PubMed ID: 16365389
[TBL] [Abstract][Full Text] [Related]
39. Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.
Matsumoto K; Obana M; Kobayashi A; Kihara M; Shioi G; Miyagawa S; Maeda M; Sakata Y; Nakayama H; Sawa Y; Fujio Y
Cardiovasc Res; 2019 Mar; 115(4):765-775. PubMed ID: 30307485
[TBL] [Abstract][Full Text] [Related]
40. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
